Zhdanov Dmitry D, Pokrovsky Vadim S, Pokrovskaya Marina V, Alexandrova Svetlana S, Eldarov Mikhail A, Grishin Dmitry V, Basharov Marsel M, Gladilina Yulia A, Podobed Olga V, Sokolov Nikolai N
Institute of Biomedical Chemistry, Pogodinskaya st., 10/8, Moscow, 119121, Russia.
N.N. Blokhin Cancer Research Center, Kashirskoe Shosse 24, Moscow, 115478, Russia.
Cancer Med. 2017 Nov;6(11):2697-2712. doi: 10.1002/cam4.1218. Epub 2017 Oct 5.
Rhodospirillum rubrum L-asparaginase mutant (RrA) down-regulates telomerase activity due to its ability to inhibit the expression of telomerase catalytic subunit hTERT. The aim of this study was to define the effect of short-term and long-term RrA exposure on proliferation of cancer Jurkat cell line and normal human CD4 T lymphocytes. RrA could inhibit telomerase activity in dose- and time-dependent manner in both Jurkat and normal CD4 T cells. Continuous RrA exposure of these cells resulted in shortening of telomeres followed by cell cycle inhibition, replicative senescence, and development of apoptosis. Complete death of Jurkat cells was observed at the day 25 of RrA exposure while normal CD4 T cells died at the day 50 due to the initial longer length of telomeres. Removal of RrA from senescent cells led to a reactivation of hTERT expression, restoration telomerase activity, re-elongation of telomeres after 48 h of cultivation, and survival of cells. These findings demonstrate that proliferation of cancer and normal telomerase-positive cells can be limited by continuous telomerase inhibition with RrA. Longer telomeres of normal CD4 T lymphocytes make such cells more sustainable to RrA exposure that could give them an advantage during anti-telomerase therapy. These results should facilitate further investigations of RrA as a potent anti-telomerase therapeutic protein.
深红螺菌L-天冬酰胺酶突变体(RrA)可下调端粒酶活性,因为它能够抑制端粒酶催化亚基hTERT的表达。本研究的目的是确定短期和长期暴露于RrA对癌症Jurkat细胞系和正常人CD4 T淋巴细胞增殖的影响。RrA可在Jurkat细胞和正常CD4 T细胞中以剂量和时间依赖性方式抑制端粒酶活性。这些细胞持续暴露于RrA会导致端粒缩短,随后细胞周期受到抑制、出现复制性衰老并发生凋亡。在暴露于RrA的第25天观察到Jurkat细胞完全死亡,而正常CD4 T细胞在第50天死亡,这是因为其端粒初始长度较长。从衰老细胞中去除RrA会导致hTERT表达重新激活、端粒酶活性恢复、培养48小时后端粒重新延长以及细胞存活。这些发现表明,持续用RrA抑制端粒酶可限制癌症细胞和正常端粒酶阳性细胞的增殖。正常CD4 T淋巴细胞较长的端粒使这些细胞对RrA暴露更具耐受性,并可能在抗端粒酶治疗期间赋予它们优势。这些结果应有助于进一步研究RrA作为一种有效的抗端粒酶治疗蛋白。